Biomarkers in COPD – Challenging, Real or Illusive
Biomarker research in COPD is becoming the most rapidly progressing sphere in respiratory medicine. Although “omics” generate a huge amount of biomarkers, fibrinogen is the only one validated by the European Medicines Agency. Thousands of studies analyzing different biological samples from the respi...
Main Authors: | Cherneva Radostina V., Kostadinov Dimitar T. |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2018-09-01
|
Series: | Folia Medica |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/folmed.2018.60.issue-3/folmed-2018-0018/folmed-2018-0018.xml?format=INT |
Similar Items
-
Epigenetic Targets for Therapeutic Approaches in COPD and Asthma. Nutrigenomics – Possible or Illusive
by: Radostina V. Cherneva, et al.
Published: (2019-09-01) -
Possible Role of Serum Leptin as Biomarker in COPD
by: Yanitsa A. Zhelyazkova, et al.
Published: (2019-12-01) -
Are blood eosinophils a prime-time biomarker for COPD management decisions?
by: Tsiligianni I, et al.
Published: (2018-06-01) -
Treatment Response Biomarkers in Asthma and COPD
by: Howraman Meteran, et al.
Published: (2021-09-01) -
Multiple biomarkers predict disease severity, progression and mortality in COPD
by: Rachel L. Zemans, et al.
Published: (2017-06-01)